Search results
19 paź 2021 · Almost any rash in a child should raise suspicion of COVID-19, especially acral rashes similar to pernio. Rashes may be subtle, mild, and morphologies may vary. Distributions may differ in children compared with adults.
4 kwi 2021 · In Part 1, we discuss one of the first and most widespread cutaneous manifestations of COVID‐19, chilblain‐like lesions, and in Part 2 we expanded to other manifestations, including erythema multiforme, urticaria and Kawasaki disease‐like inflammatory multisystemic syndrome.
Sotrovimab is indicated for children ≥ 12 years of age and weighing ≥ 40 kg with laboratory evidence of SARS-CoV-2 infection, mild to moderate COVID-19, within 10 days of symptom onset, and at high risk for progressing to severe COVID-19 and/or hospitalization [76••, 77••].
17 cze 2020 · To assess the overall prevalence of clinical signs, symptoms, and radiological findings in children and/or adolescents with COVID-19.
In this review, we summarize the current knowledge on the cutaneous manifestations of COVID-19 in children after thorough and critical review of articles published in the literature and from the personal experience of a large panel of paediatric dermatologists in Europe.
1 mar 2021 · The cutaneous signs were divided into three main categories: papular (erythemato-papular or erythemato-vesicular), urticaria, and acral lesions (chilblains). 26 Some authors have speculated that the pseudo-chilblains may be attributable to novel lifestyle changes due to COVID-19, such as decreased activity or walking barefoot in an unheated ...
4 kwi 2021 · In this review, we summarize the current knowledge on the cutaneous manifestations of COVID‐19 in children after thorough and critical review of articles published in the literature and from the personal experience of a large panel of paediatric dermatologists in Europe.
